They suggested that miR-1275 can control hepatocellular carcinoma tumor growth partially through regulating the oncogene IGF2BPs and IGF1R. It is well known that the IGF1R pathway is deregulated in ES and several studies are evaluating it as a potential target for therapy. The gene discussed is IGF1R; the disease is neoplasm.